Motor Cortex Stimulation for Facial Pain

Zoe E. Teton, Ahmed M. Raslan

Research output: Contribution to journalArticlepeer-review

Abstract

Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.

Original languageEnglish (US)
Pages (from-to)162-169
Number of pages8
JournalProgress in Neurological Surgery
Volume35
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Motor Cortex Stimulation for Facial Pain'. Together they form a unique fingerprint.

Cite this